MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for MLTX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 168 institutions reported holding MLTX, with 73.2 million shares worth $1.4 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Bvf Inc/IL | 16,001,284 | $312M | UNCHANGED |
| Deep Track Capital | 6,999,025 | $136M | INCREASED |
| T. Rowe Price | 5,322,151 | $104M | INCREASED |
| D. E. Shaw | 3,365,507 | $66M | INCREASED |
| Cormorant Asset Management | 3,205,433 | $62M | DECREASED |
Full institutional holdings, insider history, and congressional trades for MoonLake Immunotherapeutics Class A Ordinary Shares on SentiSense.